3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 4
1
Phase 3
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
20
Polycystic Ovary Syndrome
6
Infertility
4
Neoplasm Metastasis
2
Leiomyoma
2
is to Identify Biomarkers That Could Predict the Efficacy of an Adjuvant Letrozol Treatment in Postmenopausal Breast Cancer Patients.
1
Patient Acceptance of Health Care
1
Ovarian Cysts
1
Myofibroma
1
Locally Advanced Breast Cancer
1
Infertility, Female
1
Carcinoma, Ductal
1
Breast Neoplasm Malignant Female
1
Breast Carcinoma In Situ
1
Anovulation
1
Abortion, Spontaneous
1
Interventions
Solutions
1
Progesterone
1
Liraglutide
1
Letrozole
1
Injections
1
Estradiol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Infertility, Female
×
Letrozole
×
Clear all
NCT04002635
2021-01-08
LEFT
CRG UZ Brussel
Phase 4
Withdrawn